A very warm welcome to the website of the Division of Nuclear Medicine, Department of Biomedical Imaging and Image-giuded Therapy at the Medical University of Vienna. The Division of Nuclear Medicine at the General Hospital of Vienna is one of Europe's largest and most important nuclear medical departments with more than 90 staff, its room and equipment set up, the treatment ward incorporating 8 systemised beds as well as its radiochemistry/pharmacy with cyclotron facility.
In the area of imaging diagnostics all procedures of conventional nuclear medicine such as thyroid, skeleton, lung, brain and heart examinations as well as inflammation diagnostics in SPECT and SPECT/CT-Technology are offered.
In addition, the department has PET/CT and PET/MR scanners, which are used in combination with a wide range of radiopharmaceuticals for individual and customised diagnosis and therapy concepts. This is of crucial importance for the close cooperation with the Comprehensive Cancer Center (CCC) and the numerous university hospitals.
The department further focuses on nuclear medicine treatments of thyroids, liver, prostate or neuroendocrine tumours using beta and alpha radiation emitters.
We look forward to being able to welcome you to our department and want to make your stay as pleasant as possible.
Univ.-Prof. Dr. med. Marcus Hacker
head of the division of Nuclear Medicine
Der jährliche Kongress der europäischen Gesellschaft für Nuklearmedizin findet zwischen dem 9. und 13. September 2023 in Wien statt. more
Hier finden Sie Informationen zu den internen Vorträgen der Klinischen Abteilung für Nuklearmedizin. more
Das Dickdarmkarzinom ist weltweit eine der häufigsten Ursachen für krebsbedingte Todesfälle. Eine erhöhte Expression von CXCR4 wurde mit dem Auftreten von Lebermetastasen, dem Fortschreiten der Krankheit und einer verkürzten Überlebensdauer in Verbindung gebracht. Mit Hilfe von [68Ga]Pentixafor, ein
Herr Dr. Tim Wollenweber von der Klinischen Abteilung für Nuklearmedizin untersuchte in der Studie „Cardiac DPD-uptake time dependency in ATTR patients verified by quantitative SPECT/CT and semiquantitative planar parameters?“ unter der Leitung von Frau Assoc.-Profin PDin Drin Tatjana Traub-Weidinge